{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:15Z","timestamp":1792740495820,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.bpobgyn.2009.02.006","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T13:39:27Z","timestamp":1248615567000},"page":"691-709","source":"Crossref","is-referenced-by-count":80,"title":["Ovarian hyperstimulation syndrome and complications of ART"],"prefix":"10.1016","volume":"23","author":[{"given":"Veerle","family":"Vloeberghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Peeraer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pexsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2009.02.006_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"New debate: international estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib2","first-page":"73","article-title":"Assisted reproductive technologies: how to minimise the risks and complications in developing countries?","author":"De Sutter","year":"2008","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0015-0282(97)81436-7","article-title":"Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation","volume":"67","author":"Delbaere","year":"1997","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Review: diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0015-0282(98)00250-7","article-title":"Complications of medically assisted conception in 3,500 cycles","volume":"70","author":"Serour","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib10","series-title":"Ovarian hyperstimulation syndrome","first-page":"59","article-title":"Anonymous reports of lethal cases of ovarian hyperstimulation syndrome","author":"Braat","year":"2006"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib12","series-title":"In vitro fertilization and assisted reproduction","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","author":"Rizk","year":"1999"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib13","first-page":"1","article-title":"The management of ovarian hyperstimulation syndrome","volume":"5","author":"Royal College of Obstetricians and Gynaecologists (RCOG)","year":"2006","journal-title":"Green-top Guideline"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib16","author":"European Society of Human Reproduction (ESHRE)"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib17","first-page":"S178","article-title":"Ovarian hyperstimulation syndrome","volume":"86","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00404-001-0251-x","article-title":"Adnexal torsion after gonadotrophin ovulation induction for IVF of ICSI and its conservative treatment","volume":"267","author":"Gorkemli","year":"2002","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bpobgyn.2008.02.001","article-title":"Maternal morbidity and mortality in in-vitro fertilization","volume":"22","author":"K\u00e4ll\u00e9n","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0015-0282(16)53219-1","article-title":"Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy","volume":"53","author":"Mashiach","year":"1990","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7863\/jum.2001.20.3.241","article-title":"Sonographic depiction of ovarian vascularity and flow: current improvements and future applications","volume":"20","author":"Fleischer","year":"2001","journal-title":"J Ultrasound Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib22","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/humrep\/deg498","article-title":"Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function","volume":"18","author":"Oelsner","year":"2003","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humupd\/2.4.345","article-title":"The incidence of major clinical complications in a Dutch transport IVF programme","volume":"2","author":"Roest","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib24","doi-asserted-by":"crossref","unstructured":"Maxwell KN, Cholst IN, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril 2008; 90(6): 2165\u20132171.","DOI":"10.1016\/j.fertnstert.2007.10.065"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0301-2115(97)00263-7","article-title":"Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer","volume":"77","author":"Govaerts","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1472-6483(10)60200-3","article-title":"Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles","volume":"17","author":"Bodri","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.thromres.2007.05.023","article-title":"Review article: the \u201cART\u201d of thromboembolism: a review of assisted reproductive technology and thromboembolic complications","volume":"121","author":"Chan","year":"2008","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.bpobgyn.2009.02.006_bib28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/humrep\/12.10.2167","article-title":"Opinion: thromboembolic disease associated with ovarian stimulation and assisted conception techniques","volume":"12","author":"Stewart","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib29","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1538-7836.2006.02026.x","article-title":"Review article: a review of upper extremity deep vein thrombosis in pregnancy: unmasking the \u2018ART\u2019 behind the clot","volume":"4","author":"Chan","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib30","first-page":"312","article-title":"Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study","volume":"69","author":"M\u00e1ra","year":"2004","journal-title":"Ceska Gynekol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0015-0282(16)57987-4","article-title":"Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism","volume":"64","author":"Kodama","year":"1995","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0015-0282(16)58512-4","article-title":"Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome","volume":"66","author":"Kodama","year":"1996","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0015-0282(16)58576-8","article-title":"Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome","volume":"66","author":"Balasch","year":"1996","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0889-8588(05)70143-X","article-title":"Thromboembolic complications associated with reproductive endocrinologic procedures","volume":"14","author":"Baumann","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2141.2001.03081.x","article-title":"Short report: internal jugular vein thrombosis after assisted conception therapy","volume":"115","author":"Arya","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0015-0282(01)03218-6","article-title":"Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome","volume":"77","author":"Dulitzky","year":"2002","journal-title":"Fertil Steril"},{"issue":"16","key":"10.1016\/j.bpobgyn.2009.02.006_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Medical progress. Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2009.02.006_bib38","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1093\/humrep\/13.10.2718","article-title":"Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome","volume":"13","author":"Balasch","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1196\/annals.1365.021","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"1092","author":"Vlahos","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/humrep\/deg116","article-title":"Debate: bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome","volume":"18","author":"Amarin","year":"2003","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2006-1231","article-title":"Vascular endothelial cadherin regulates vascular permeability: implications for ovarian hyperstimulation syndrome","volume":"92","author":"Villasante","year":"2007","journal-title":"J Clin Endocr Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"11","key":"10.1016\/j.bpobgyn.2009.02.006_bib43","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2002-220204","article-title":"Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade","volume":"143","author":"G\u00f3mez","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"issue":"43","key":"10.1016\/j.bpobgyn.2009.02.006_bib45","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib47","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","article-title":"Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability","volume":"68","author":"G\u00f3mez","year":"2003","journal-title":"Biol Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(97)81908-5","article-title":"Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome","volume":"67","author":"Abramov","year":"1997","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.bpobgyn.2009.02.006_bib49","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/oxfordjournals.humrep.a136327","article-title":"Research-article: endocrinology and paracrinology: urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment","volume":"10","author":"Robertson","year":"1995","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(98)00447-6","article-title":"Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome","volume":"71","author":"Agrawal","year":"1999","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1\u03b2, and interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib52","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1210\/jc.80.6.1967","article-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J Clin Endocr Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/molehr\/4.3.203","article-title":"Secretion of vascular endothelial growth factor\/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent","volume":"4","author":"Neulen","year":"1998","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib54","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/humrep\/del005","article-title":"Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome","volume":"21","author":"Pau","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/rep.1.00129","article-title":"Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats","volume":"127","author":"G\u00f3mez","year":"2004","journal-title":"Reproduction"},{"issue":"11","key":"10.1016\/j.bpobgyn.2009.02.006_bib56","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1210\/en.2006-0657","article-title":"Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model","volume":"147","author":"G\u00f3mez","year":"2006","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib57","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1093\/humrep\/dem315","article-title":"Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study","volume":"22","author":"Alvarez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib58","series-title":"Infertility in practice","first-page":"359","article-title":"Complications of ovarian stimulation","author":"Balen","year":"2008"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0015-0282(16)59290-5","article-title":"Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome","volume":"48","author":"Na vot","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib60","series-title":"Ovarian hyperstimulation syndrome","first-page":"97","article-title":"Renin-angiotensin system in the pathophysiology of ovarian hyperstimulation syndrome","author":"Teruel","year":"2006"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib61","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0015-0282(01)02869-2","article-title":"Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit","volume":"76","author":"Teruel","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-121-1-199407010-00005","article-title":"Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome","volume":"121","author":"Balasch","year":"1994","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib63","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/humrep\/15.5.1043","article-title":"Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed serum follicle stimulating concentrations in a triplet pregnancy","volume":"15","author":"Check","year":"2000","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.bpobgyn.2009.02.006_bib64","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/humrep\/13.8.2082","article-title":"Case report: ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS","volume":"13","author":"Ludwig","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib65","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9378(98)70448-X","article-title":"Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome","author":"Nappi","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib66","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humrep\/deh124","article-title":"New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?","volume":"19","author":"Delbaere","year":"2004","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.bpobgyn.2009.02.006_bib67","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa030064","article-title":"Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor","volume":"349","author":"Smits","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/ENDO:26:3:285","article-title":"Understanding ovarian hyperstimulation syndrome","volume":"26","author":"Delbaere","year":"2005","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Review: gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib70","doi-asserted-by":"crossref","unstructured":"Zhao JZ, Zhou W, Zhang W, et\u00a0al. Clinical Article: In vitro maturation and fertilization of oocytes from unstimulated ovaries in infertile women with polycystic ovary syndrome. Fertil Steril, in press. doi:10.1016\/j.fertnstert.2008.03.059.","DOI":"10.1016\/j.fertnstert.2008.03.059"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/humupd\/8.3.291","article-title":"A qualitative systematic review of coasting, a procedure to avoid hyperstimulation syndrome in IVF patients","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.bpobgyn.2009.02.006_bib72","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/oxfordjournals.humrep.a137276","article-title":"Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups","volume":"6","author":"Asch","year":"1991","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib73","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/oxfordjournals.humrep.a135867","article-title":"\u2018Prolonged coasting\u2019: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization","volume":"10","author":"Sher","year":"1995","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0015-0282(98)00438-5","article-title":"Withholding gonadotropins (\u201ccoasting\u201d) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles","volume":"71","author":"Fluker","year":"1999","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.bpobgyn.2009.02.006_bib75","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/humrep\/deh298","article-title":"Coasting acts through downregulation of VEGF gene expression and protein secretion","volume":"19","author":"Garc\u00eda-Velasco","year":"2004","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib76","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/humrep\/deg230","article-title":"Opinion: coasting-what is the best formula?","volume":"18","author":"Levinsohn\u2013Tavor","year":"2003","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib77","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.fertnstert.2005.07.1335","article-title":"Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?","volume":"85","author":"Garc\u00eda-Velasco","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib78","article-title":"Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome","author":"D'Angelo","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib79","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/16.12.2491","article-title":"Opinion: preventive attitude of physicians to avoid OHSS in IVF patients","volume":"16","author":"Delvigne","year":"2001","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib80","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humrep\/deg166","article-title":"Debate: prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos","volume":"18","author":"Orvieto","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib81","author":"Gerris"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/humrep\/17.2.310","article-title":"The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles","volume":"17","author":"Ulug","year":"2002","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib83","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1472-6483(10)61633-1","article-title":"Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization","volume":"9","author":"Moreno","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib84","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","article-title":"Reducing the dose of human chorionic gonadotropin in high responders does affect the outcomes of in vitro fertilization","volume":"82","author":"Schmidt","year":"2004","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib85","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1210\/jc.86.6.2607","article-title":"Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study","volume":"86","author":"The European Recombinant LH Study Group","year":"2001","journal-title":"J Clin Endocr Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10815-008-9198-1","article-title":"GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?","volume":"25","author":"Kol","year":"2008","journal-title":"J Assist Reprod Genet"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib88","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/humrep\/17.12.3027","article-title":"Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane Review","volume":"17","author":"Aboulghar","year":"2002","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.bpobgyn.2009.02.006_bib89","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib90","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/humrep\/12.12.2599","article-title":"Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme","volume":"12","author":"Graf","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0301-2115(00)00452-8","article-title":"Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study","volume":"96","author":"Gokmen","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2009.02.006_bib92","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/13.9.2421","article-title":"Prophylactic intravenous hydroxyethyl starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized, double-blind and placebo-controlled study","volume":"13","author":"K\u00f6nig","year":"1998","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002806.pub2","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome","author":"D'Angelo","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bpobgyn.2009.02.006_bib94","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/humrep\/17.10.2548","article-title":"Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos","volume":"17","author":"Endo","year":"2002","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib95","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/humupd\/dmm021","article-title":"An update of luteal phase support in stimulated IVF cycles","volume":"13","author":"Fatemi","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/oxfordjournals.humrep.a137613","article-title":"Dopamine treatment for severe ovarian hyperstimulation syndrome","volume":"7","author":"Ferraretti","year":"1992","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.bpobgyn.2009.02.006_bib97","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1097\/01.CCM.0000182795.31757.CE","article-title":"Ovarian hyperstimulation syndrome","volume":"33","author":"Budev","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib98","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1749-6632.1985.tb37519.x","article-title":"Transvesical and transvaginal approaches for the aspiration of follicles by use of ultrasound","volume":"442","author":"Wikland","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib99","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.humrep.a137708","article-title":"Short communication: clinical complications during in-vitro fertilization treatment","volume":"7","author":"Bergh","year":"1992","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF01204444","article-title":"Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures","volume":"10","author":"Bennett","year":"1993","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"10.1016\/j.bpobgyn.2009.02.006_bib101","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0015-0282(16)55997-4","article-title":"Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer","volume":"59","author":"Dicker","year":"1993","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2009.02.006_bib102","first-page":"590","article-title":"Perioperative complications arising after transvaginal oocyte retrieval","volume":"81","author":"Tureck","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib103","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/humrep\/deh755","article-title":"Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE","volume":"20","author":"Nyboe Andersen","year":"2005","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.bpobgyn.2009.02.006_bib104","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/humrep\/del278","article-title":"Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals","volume":"21","author":"Ludwig","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1067\/mob.2001.108994","article-title":"Defining the incidence of serious complications experienced by oocyte donors: A review of 1000 cases","author":"Sauer","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib106","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(00)00637-3","article-title":"Massive retroperitoneal bleeding: a complication of transvaginal ultrasonography-guided oocyte retrieval for in vitro fertilization \u2013 embryo transfer","volume":"74","author":"Azem","year":"2000","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2009.02.006_bib107","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/humrep\/12.5.948","article-title":"Case report: ureteral lesion secondary to vaginal ultrasound follicular puncture for oocyte recovery in in-vitro fertilization","volume":"12","author":"Coroleu","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib108","doi-asserted-by":"crossref","unstructured":"von Eye Corleta H, Moretto M, D'Avila AM, et\u00a0al. Case Report: Immediate ureterovaginal fistula secondary to oocyte retrieval \u2013 a case report. Fertil Steril 2008; 90(5): 2006.e1\u20132006.e3.","DOI":"10.1016\/j.fertnstert.2008.03.005"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib109","unstructured":"Mongiu AK, Helfand BT, Kielb SJ. Case report: ureterovaginal fistula formation after oocyte retrieval. J Urol 2009; 16(1): 4519\u20134521."},{"issue":"11","key":"10.1016\/j.bpobgyn.2009.02.006_bib110","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/humrep\/del252","article-title":"Uro-retroperitoneum after ultrasound-guided transvaginal follicle puncture in an oocyte donor: a case report","volume":"21","author":"Fiori","year":"2006","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2009.02.006_bib111","article-title":"Case report: laparoscopic ureteral reimplantation for ureteral lesion secondary to transvaginal ultrasonography for oocyte retrieval","volume":"58","author":"Fugita","year":"2001","journal-title":"J Urol."},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib112","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.fertnstert.2004.01.044","article-title":"Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilization","volume":"82","author":"El-Shawarby","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib113","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.ajog.2007.01.025","article-title":"Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval","author":"Moayeri","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2009.02.006_bib114","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1023\/A:1009468222103","volume":"18","author":"Battaglia","year":"2001","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0015-0282(01)01858-1","article-title":"Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization","volume":"76","author":"Dessole","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2009.02.006_bib116","doi-asserted-by":"crossref","first-page":"219.e11","DOI":"10.1016\/j.fertnstert.2005.12.045","article-title":"Transvaginal oocyte retrieval for in vitro fertilization complicated by ovarian abcess during pregnancy","volume":"86","author":"Sharpe","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10815-006-9090-9","article-title":"Case report: bilateral ovarian abscesses following transvaginal oocyte retrieval for IVF: a case report and review of literature","volume":"24","author":"Kelada","year":"2007","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"10.1016\/j.bpobgyn.2009.02.006_bib118","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/humrep\/13.7.1813","article-title":"Case report: ovarian abscess after ovum retrieval for in-vitro fertilization","volume":"13","author":"Dicker","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.02.006_bib119","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/oxfordjournals.humrep.a135913","article-title":"Case report: perforated appendicitis and ectopic pregnancy following in-vitro fertilization","volume":"10","author":"Akman","year":"1995","journal-title":"Hum Reprod"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693409000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693409000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T02:41:01Z","timestamp":1633747261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693409000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1521693409000662"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.02.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}